pentobarbital will lower the extent or outcome of lumefantrine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Coadministration with solid CYP3A4 inducers may end up in decreased serum concentrations and loss of antimalarial efficacy pentobarbital will lessen the level